{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:01Z","timestamp":1793830921030,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40261-026-01553-z","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:51:14Z","timestamp":1778327474000},"page":"691-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Topical Antibiotic Monotherapy Only Provides Mild Benefit for Patients with Acne Vulgaris: A Systematic Review and Network Meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Meng","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-2608","authenticated-orcid":false,"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"1553_CR1","unstructured":"Institute for Health Metrics and Evaluation (IHME). In: GBD 2019 cause and risk GBD acne vulgaris-level 3 cause. 2019. https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/acne-vulgaris-level-3-cause. Accessed 7 Nov 2024."},{"key":"1553_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019;20:345\u201365. https:\/\/doi.org\/10.1007\/s40257-019-00423-z.","journal-title":"Am J Clin Dermatol"},{"key":"1553_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1503\/cmaj.140665","volume":"188","author":"Y Asai","year":"2016","unstructured":"Asai Y, Baibergenova A, Dutil M, Humphrey S, Hull P, Lynde C, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016;188:118\u201326. https:\/\/doi.org\/10.1503\/cmaj.140665.","journal-title":"CMAJ"},{"key":"1553_CR4","unstructured":"NHS Business Services Authority. Prescription cost analysis (PCA) data. 2021. https:\/\/www.nhsbsa.nhs.uk\/prescription-data\/dispensing-data\/prescription-cost-analysis-pca-data. Accessed 16 Mar 2024."},{"key":"1553_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40257-018-00417-3","volume":"20","author":"H Xu","year":"2019","unstructured":"Xu H, Li H. Acne, the skin microbiome, and antibiotic treatment. Am J Clin Dermatol. 2019;20:335\u201344. https:\/\/doi.org\/10.1007\/s40257-018-00417-3.","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl. 1","key":"1553_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"A Nast","year":"2012","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl. 1):1\u201329. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04374.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1553_CR7","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90:1006.e1-30. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.017.","journal-title":"J Am Acad Dermatol"},{"key":"1553_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1370\/afm.2995","volume":"21","author":"CY Huang","year":"2023","unstructured":"Huang CY, Chang IJ, Bolick N, Hsu W-T, Su C-H, Hsieh T-S, et al. Comparative efficacy of pharmacological treatments for acne vulgaris: a network meta-analysis of 221 randomized controlled trials. Ann Fam Med. 2023;21:358\u201369. https:\/\/doi.org\/10.1370\/afm.2995.","journal-title":"Ann Fam Med"},{"key":"1553_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bjd.20080","volume":"185","author":"B Stuart","year":"2021","unstructured":"Stuart B, Maund E, Wilcox C, Sridharan K, Sivaramakrishnan G, Regas C, et al. Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis. Br J Dermatol. 2021;185:512\u201325. https:\/\/doi.org\/10.1111\/bjd.20080.","journal-title":"Br J Dermatol"},{"key":"1553_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"key":"1553_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/bjd.18011","volume":"181","author":"DM Thiboutot","year":"2019","unstructured":"Thiboutot DM, Layton AM, Chren MM, Eady EA, Tan J. Assessing effectiveness in acne clinical trials: steps towards a core outcome measure set. Br J Dermatol. 2019;181:700\u20136. https:\/\/doi.org\/10.1111\/bjd.18011.","journal-title":"Br J Dermatol"},{"key":"1553_CR12","unstructured":"German Astrophysical Virtual Observatory (GAVO). Dexter: data extraction from graph images. 2008.: https:\/\/dc.zah.uni-heidelberg.de\/sdexter. Accessed 2 Nov 2025."},{"key":"1553_CR13","doi-asserted-by":"publisher","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions. 2019. https:\/\/doi.org\/10.1002\/9781119536604.ch8.","DOI":"10.1002\/9781119536604.ch8"},{"issue":"7650","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.","journal-title":"BMJ"},{"key":"1553_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0829-2","volume":"19","author":"A B\u00e9liveau","year":"2019","unstructured":"B\u00e9liveau A, Boyne DJ, Slater J, Brenner D, Arora P. BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network meta-analyses. BMC Med Res Methodol. 2019;19:196. https:\/\/doi.org\/10.1186\/s12874-019-0829-2.","journal-title":"BMC Med Res Methodol"},{"key":"1553_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1365-4632.2010.04601.x","volume":"49","author":"M Tunca","year":"2010","unstructured":"Tunca M, Akar A, Ozmen I, Erbil H. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne. Int J Dermatol. 2010;49:1440\u20134. https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04601.x.","journal-title":"Int J Dermatol"},{"issue":"5","key":"1553_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40257-024-00879-8","volume":"25","author":"KK Lovell","year":"2024","unstructured":"Lovell KK, Momin RI, Sangha HS, Feldman SR, Pichardo RO. Dapsone use in dermatology. Am J Clin Dermatol. 2024;25(5):811\u201322. https:\/\/doi.org\/10.1007\/s40257-024-00879-8.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1553_CR18","doi-asserted-by":"publisher","first-page":"439.e1","DOI":"10.1016\/j.jaad.2006.10.005","volume":"56","author":"ZD Draelos","year":"2007","unstructured":"Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1-10. https:\/\/doi.org\/10.1016\/j.jaad.2006.10.005.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.det.2008.07.008","volume":"27","author":"JJ Leyden","year":"2009","unstructured":"Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin. 2009;27(1):1\u201315. https:\/\/doi.org\/10.1016\/j.det.2008.07.008.","journal-title":"Dermatol Clin"},{"issue":"6","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11046-021-00586-6","volume":"186","author":"X Xu","year":"2021","unstructured":"Xu X, Ran X, Tang J, Pradhan S, Dai Y, Zhuang K, et al. Skin microbiota in non-inflammatory and inflammatory lesions of acne vulgaris: the underlying changes within the pilosebaceous unit. Mycopathologia. 2021;186(6):863\u20139. https:\/\/doi.org\/10.1007\/s11046-021-00586-6.","journal-title":"Mycopathologia"},{"issue":"1","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/lsm.23008","volume":"51","author":"CSK Fuchs","year":"2019","unstructured":"Fuchs CSK, Andersen AJB, Ardigo M, Philipsen PA, Haedersdal M, Mogensen M. Acne vulgaris severity graded by in vivo reflectance confocal microscopy and optical coherence tomography. Lasers Surg Med. 2019;51(1):104\u201313. https:\/\/doi.org\/10.1002\/lsm.23008.","journal-title":"Lasers Surg Med"},{"issue":"Suppl. 2","key":"1553_CR22","first-page":"109","volume":"16","author":"J Molg\u00f3","year":"1985","unstructured":"Molg\u00f3 J, Lemeignan M, Peradejordi F, Lechat P. Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates. J Pharmacol. 1985;16(Suppl. 2):109\u201344.","journal-title":"J Pharmacol"},{"issue":"3","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159\u201375. https:\/\/doi.org\/10.1038\/nri3399.","journal-title":"Nat Rev Immunol"},{"key":"1553_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000051771","volume":"203","author":"CC Zouboulis","year":"2001","unstructured":"Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203:277\u20139. https:\/\/doi.org\/10.1159\/000051771.","journal-title":"Dermatology"},{"key":"1553_CR25","first-page":"27","volume":"6","author":"EA Tanghetti","year":"2013","unstructured":"Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6:27\u201335.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/exd.14172","volume":"29","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis CC. Endocrinology and immunology of acne: two sides of the same coin. Exp Dermatol. 2020;29(9):840\u201359. https:\/\/doi.org\/10.1111\/exd.14172.","journal-title":"Exp Dermatol"},{"issue":"1","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/jdv.20061","volume":"39","author":"CC Zouboulis","year":"2025","unstructured":"Zouboulis CC, Kollias N. Acne lesions cycle. J Eur Acad Dermatol Venereol. 2025;39(1):e29-31. https:\/\/doi.org\/10.1111\/jdv.20061.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jdv.20154","volume":"39","author":"EE Kakpovbia","year":"2025","unstructured":"Kakpovbia EE, Young T, Milam EC, Qian Y, Yassin S, Nicholson J, et al. Efficacy of topical treatments for mild-to-moderate acne: a systematic review and meta-analysis of randomized control trials. J Eur Acad Dermatol Venereol. 2025;39(4):775\u201384. https:\/\/doi.org\/10.1111\/jdv.20154.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1553_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jclinepi.2022.01.023","volume":"145","author":"V Smail-Faugeron","year":"2022","unstructured":"Smail-Faugeron V, Tan A, Caille A, Yordanov Y, Hajage D, Tubach F, et al. Meta-analyses frequently include old trials that are associated with a larger intervention effect: a meta-epidemiological study. J Clin Epidemiol. 2022;145:144\u201353. https:\/\/doi.org\/10.1016\/j.jclinepi.2022.01.023.","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01553-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01553-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01553-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:29:48Z","timestamp":1783160988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01553-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01553-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Meng Lyu, Wenxin Fan, Haihui Yang, Xufei Luo, Gang Wang, and Guannan Zhu have no relevant financial or non-financial interests to disclose. Christos C. Zouboulis has received disease-relevant honoraria as a consultant for Almirall, Est\u00e9e Lauder, NAOS-BIODERMA, and PPM and lecture honoraria from NAOS-BIODERMA and L\u2019Or\u00e9al, and has non-financial interests as chair of the ARHS Task Force group of the European Academy of Dermatology and Venereology and Editor of the EADV News.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available from the corresponding authors upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors read and approved the final version. Their specific contributions are as follows: ML, WF, and HY led the comprehensive data refinement, performed additional analyses, and substantially revised the manuscript text. XL assisted with PROSPERO registration and provided technical support during the initial submission. GW provided the initial conceptualization and guidance. GZ conceived and designed the study, coordinated the revision process, and drafted the Discussion section. CCZ supervised the research framework and provided critical intellectual input throughout the revision.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}